Healthcare Industry News: Mazor Robotics
News Release - December 20, 2011
Mazor Robotics Enters US Spine Ambulatory Surgery Center MarketCompany Signs Agreement with the Lakes Surgery Center
New Renaissance™ System Enables Spinal Endoscopy, Including Ambulatory, Minimally Invasive Treatment of Disc Diseases
CAESAREA, Israel--(Healthcare Sales & Marketing Network)-- Mazor Robotics Ltd (TASE: MZOR.TA ), the leader in innovative surgical robots and complementary products for spine surgery, announced a purchase agreement with NSH Michigan, Inc. The Renaissance™ system will be installed at NSH Michigan, Inc.'s affiliate, the Lakes Surgery Center, in West Bloomfield, Michigan. The Renaissance system was recently launched as the new generation of Mazor Robotics Guidance Systems.
“Our clinical experiences with Mazor Robotics’ technology, including examination of numerous peer-reviewed studies and hands-on demonstrations, has convinced us to add Renaissance to our surgical program,” said Ms. Jennifer Butterfield, CEO of Lakes Surgery Center. “We believe that Mazor Robotics’ Renaissance system will differentiate our facility by enabling us to raise the level of patient care, for spinal endoscopy as well as for other spine procedures.”
“Many of my spine surgery referrals are for spinal endoscopy procedures,” said Kevin Lee, MD, a leading neurosurgeon and pain management / spinal endoscopy specialist at Lakes Surgery Center. “Demand for minimally invasive surgery has grown dramatically in recent years, and as technology advances we see improvement in patient outcomes. We recognize the tremendous potential of Renaissance; it is the next step in the evolution of incorporating state-of-the-art technology for better patient care. Mazor Robotics’ technology will take these procedures to the next level by providing a safer and more accurate way to enter the surgical site, reduce intra-operative radiation, shorten procedure time, and reduce complications."
“This purchase agreement with NSH Michigan, Inc. is strategically important for Mazor Robotics as it significantly expands our market opportunity to include ambulatory surgery centers in the U.S.,” said Ori Hadomi, CEO of Mazor Robotics. “We are also excited about the clinical opportunity this represents, as many more patients will now have access to such minimally invasive procedures."
About Mazor Robotics
Mazor Robotics Ltd (TASE: MZOR.TA ) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and OR staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 15,000 implants in the USA and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, visit www.mazorrobotics.com
Source: Mazor Robotics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.